{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:11:27Z","timestamp":1784693487070,"version":"3.55.0"},"reference-count":47,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T00:00:00Z","timestamp":1324252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives\/Hypothesis:<\/jats:title><jats:p>To evaluate the hearing changes and quality\u2010of\u2010life outcomes of 393 cases of streptomycin\/dexamethasone inner ear perfusion performed by the primary author on 312 ears of 299 patients with Meniere's disease between July 2002 and May 2010.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design:<\/jats:title><jats:p>Retrospective chart review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Objective arm: A database was used to compile pretreatment and post\u2010treatment audiograms as well as basic demographic information, dates of treatment, number of treatments, and which ear was treated. All patients met the 1995 American Academy of Otolaryngology\u2013Head and Neck Surgery Committee on Hearing and Equilibrium Guidelines for the diagnosis and evaluation of therapy in Meniere's disease. All patients underwent one or more 3\u2010day treatments consisting of daily intratympanic injections of a low\u2010dose streptomycin\/high\u2010dose dexamethasone mixture plus intravenous dexamethasone. The end point for treatment was adequate control of vertigo. Subjective arm: The Meniere's Disease Outcomes Questionnaire survey was used to assess patients' quality of life after receiving streptomycin\/dexamethasone inner ear perfusion. All procedures were performed by the primary author at the Shea Ear Clinic, a tertiary\u2010referral otology clinic and outpatient surgery center.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>After a single 3\u2010day treatment, the average change in pure tone average was 0.89 dB (\u00b111). The average change in word recognition score was 0.49% (\u00b117). The average number of days from treatment to follow\u2010up audiogram was 94 with a range of 8 to 1,603. Clinically significant hearing loss occurred after 62 of 393 (15.7%) treatments. Severe hearing loss occurred after 20 of 393 treatments (5.0%). The percentage of ears with clinically significant hearing loss after all treatments was 56 of 312 (17.9%). A total of 215 surveys were returned from 383 patients (56.1%) to whom they were mailed. There were 90% of patients who indicated improvement in quality of life after treatment and 88% who indicated improvement in their \u201cvertigo subscore,\u201d a domain within the survey that focuses on vertigo control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Streptomycin\/dexamethasone inner ear perfusion is as safe to the hearing of patients with Meniere's disease as other aminoglycoside regimens and provides a significant improvement in quality of life.Laryngoscope, 122:204\u2013211, 2012<\/jats:p><\/jats:sec>","DOI":"10.1002\/lary.22362","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T21:28:45Z","timestamp":1324330125000},"page":"204-211","source":"Crossref","is-referenced-by-count":22,"title":["Hearing results and quality of life after streptomycin\/dexamethasone perfusion for meniere's disease"],"prefix":"10.1002","volume":"122","author":[{"given":"Paul F.","family":"Shea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis A.","family":"Richey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim Y.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne R.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,12,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e3181453a3c"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199102000-00020"},{"key":"e_1_2_6_4_2","first-page":"415","article-title":"10\u2010year review of endolymphatic sac surgery for intractable meniere disease","volume":"39","author":"Hu A","year":"2010","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348940811701201"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1981.00790410009002"},{"key":"e_1_2_6_7_2","first-page":"259","article-title":"Placebo effect in surgery for Meniere's disease: nine\u2010year follow\u2010up","volume":"10","author":"Bretlau P","year":"1989","journal-title":"Am J Otol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200402000-00008"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0030-6665(20)30147-X","article-title":"The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease","volume":"30","author":"Shea JJ","year":"1997","journal-title":"Otolaryngol Clin North Am"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199907001-00001"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2005.05.010"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0030-6665(20)30398-4","article-title":"Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease","author":"Shea JJ","year":"1996","journal-title":"Otolaryngol Clin North Am"},{"key":"e_1_2_6_13_2","first-page":"196","article-title":"Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double\u2010blind, crossover trial","volume":"19","author":"Silverstein H","year":"1998","journal-title":"Am J Otol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200002010-00009"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200303000-00027"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016489109138398"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215108003150"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","article-title":"Committee on Hearing and Eqilibrium Guidelines for the diagnosis and evaluation of therapy in Meniere's disease","volume":"113","author":"Equilibrium CoHa","year":"1995","journal-title":"Otolarngol Head Neck Surg"},{"key":"e_1_2_6_19_2","first-page":"67","article-title":"Long\u2010term effects of Meniere's disease on hearing and quality of life","volume":"18","author":"Kinney SE","year":"1997","journal-title":"Am J Otol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200111000-00030"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.2003.00740.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215106001605"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200405000-00023"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e31817ef4e3"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000233815.71671.6c"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200209000-00032"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(02)00014-2"},{"key":"e_1_2_6_28_2","first-page":"293","article-title":"Streptomycin treatment of vertigo","volume":"52","author":"Fowler EP","year":"1948","journal-title":"Trans Am Acad Opthamol Otolaryngol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348945206100317"},{"key":"e_1_2_6_30_2","first-page":"1","article-title":"Ablation therapy in the management of Meniere's disease","volume":"132","author":"Schuknect HF","year":"1957","journal-title":"Acta Otolaryngol Suppl"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00455886"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016489109128052"},{"key":"e_1_2_6_33_2","first-page":"18","article-title":"Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease","volume":"13","author":"Nedzelski JM","year":"1992","journal-title":"Am J Otol"},{"key":"e_1_2_6_34_2","first-page":"209","article-title":"Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy","volume":"20","author":"Minor LB","year":"1999","journal-title":"Am J Otol"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459988409200218"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/hn.1999.v120.a91763"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.35.36"},{"key":"e_1_2_6_38_2","first-page":"2944","volume-title":"Cummings Otolaryngology Head & Neck Surgery","author":"Lalwani AK","year":"2005"},{"key":"e_1_2_6_39_2","first-page":"170","article-title":"Dose\u2010related vestibular and cochlear effects of transtympanic gentamicin","volume":"19","author":"Wanamaker HH","year":"1998","journal-title":"Am J Otol"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348948809700602"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.4.467"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-59989570313-6"},{"key":"e_1_2_6_43_2","unstructured":"NorrisCH AubertA SheaJJ.Comparison of cochleotoxicity and vestibulotoxicity of streptomycin and gentamicin. Meniere's Disease: Perspectives in the '90s pp 485\u2013490.Proceedings of the Third International Symposium on Meniere's Disease. Rome Italy October 20\u201323 1993. Amsterdam\/New York: Kugler Publications 1994."},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200407000-00023"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000149439.43478.24"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.moo.0000134438.91734.38"},{"key":"e_1_2_6_47_2","first-page":"224","article-title":"Classification of Meniere's disease","volume":"14","author":"Shea JJ Jr","year":"1993","journal-title":"Am J Otol"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459988910000102"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flary.22362","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.22362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T22:58:59Z","timestamp":1696892339000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lary.22362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,19]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1002\/lary.22362"],"URL":"https:\/\/doi.org\/10.1002\/lary.22362","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,19]]}}}